Reduced plasminogen activator activity in patients with inactive ulcerative colitis
Rask, H.; Mortensen, J.Z.
Ugeskrift for Laeger 148(45): 2915-2916
1986
ISSN/ISBN: 0041-5782 PMID: 3787832 Document Number: 272554
Document emailed within 1 workday
Related Documents
Han, X.M.; Chen, Z.Q.; Mao, H.M. 1990: Determination of plasma tissue type plasminogen activator and plasminogen activator inhibitor activity in patients with ischemic stroke Zhonghua Nei Ke Za Zhi 29(9): 544-546; 575-576Jørgensen, M.; Mortensen, J.Z.; Madsen, A.G.; Thorsen, S.; Jacobsen, B. 1983: A family with reduced plasminogen activator activity in the blood associated with recurrent thrombosis Ugeskrift for Laeger 145(30): 2302-2303
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Yamada, R.; Yamada, S.; Ishii, A.; Tane, S. 1993: Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-1 in blood obtained from patients of idiopathic central serous chorioretinopathy Nippon Ganka Gakkai Zasshi 97(8): 955-960
Kobayashi, Y.; Fukuo, Y.; Shibuya, T.; Terashi, A. 1990: The correlation between the activity of tissue plasminogen activator (TPA), levels of tissue plasminogen activator inhibitor (PAI-1) antigen and serum lipids in healthy subjects Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 27(5): 578-583
Harbeck, N.; Kates, R.E.; Look, M.P.; Meijer-Van Gelder, M.E.; Klijn, J.G.M.; Krüger, A.; Kiechle, M.; Jänicke, F.; Schmitt, M.; Foekens, J.A. 2002: Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424) Cancer Research 62(16): 4617-4622
Lakatos, L.ás.ó; Mester, G.áb.; Erdélyi, Z.; David, G.; Pandúr, T.ün.; Balogh, M.ál.; Fischer, S.; Vargha, P.ét.; Lakatos, P.ét.L.ás.ó 2006: Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients Orvosi Hetilap 147(4): 175-181
Casellas, F.; Vaquero, E.; Armengol, J.R.; Malagelada, J.R. 1999: Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis Hepato-Gastroenterology 46(28): 2343-2346
De Moerloose, P.; Mermillod, N.; Amiral, J.; Reber, G. 1998: Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1 Thrombosis and Haemostasis 79(3): 554-556
Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Fukao, H.; Yamamoto, K.; Matsuo, O. 1991: Levels of tissue-type plasminogen activator and plasminogen activator inhibitor 1 in disseminated intravascular coagulation syndrome Rinsho Byori. Japanese Journal of Clinical Pathology 39(7): 720-726
Wallnöfer, A.E.; van Griensven, J.M.; Schoemaker, H.C.; Cohen, A.F.; Lambert, W.; Kluft, C.; Meijer, P.; Kooistra, T. 1993: Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans Thrombosis and Haemostasis 70(6): 1005-1008
Shiba, E.; Kobayashi, T.; Yayoi, E.; Takatsuka, Y.; Koyama, H.; Takai, S.; Mori, T. 1992: Measurement of plasminogen activator and plasminogen activator inhibitor in breast cancer tissue: preliminary report Nihon Geka Gakkai Zasshi 93(1): 109
Von Tempelhoff, G.F.; Heilmann, L.; Dietrich, M.; Schneider, D.; Niemann, F.; Hommel, G. 1997: Plasmatic plasminogen activator inhibitor activity in patients with primary breast cancer Thrombosis and Haemostasis 77(3): 606-608
Virji, M.A.; Aggarwal, S.; Kang, Y. 1989: Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation Transplantation Proceedings 21(3): 3540-3541
Seo, M.; Okada, M.; Yao, T.; Okabe, N.; Maeda, K.; Oh, K. 1995: Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification American Journal of Gastroenterology 90(10): 1759-1763
Gyde, S.N.; Prior, P.; Alexander, F.; Evans, S.; Taylor, K.; John, W.G.; Waterhouse, J.A.; Allan, R.N. 1984: Ulcerative colitis: why is the mortality from cardiovascular disease reduced? Quarterly Journal of Medicine 53(211): 351-357
Seo, M.; Okada, M.; Yao, T.; Ueki, M.; Arima, S.; Okumura, M. 1992: An index of disease activity in patients with ulcerative colitis American Journal of Gastroenterology 87(8): 971-976
Kowal-Gierczak, B.; Hańczyc, H.; Falowska-Adamczyk, W. 1974: Muramidase activity in feces of patients with ulcerative colitis Polski Tygodnik Lekarski 29(6): 223-224
Nelles, L.; Lijnen, H.R.; Van Nuffelen, A.; Demarsin, E.; Collen, D. 1990: Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA) Thrombosis and Haemostasis 64(1): 53-60